ConductScience.org, home

Paper805382

Ethosuximide in the treatment of absence (peptit mal) seizures.

Browne TR and 7 others. Neurology, 1975. Cited by 115 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Ethosuximide in the treatment of absence (peptit mal) seizures. Papers, record 805382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/805382

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ethosuximide in the treatment of absence (peptit mal) seizures.
PubMed
Journal
Neurology
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
5.42
iCite
Revised in PubMed
2019-05-14
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Browne TRT R
2Dreifuss FEF E
3Dyken PRP R
4Goode DJD J
5Penry JKJ K
6Porter RJR J
7White BGB G
8White PTP T

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epilepsy, AbsenceMajor topic
EthosuximideMajor topic
Adolescent
Child
Child, Preschool
Clinical Trials as Topic
Dose-Response Relationship, Drug
Electroencephalography
Female
Half-Life
Humans
Male
Psychological Tests
Wechsler Scales

Source PubMed

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
30,597,542Spontaneous epileptiform activity in a rat model of bilateral subcortical band heterotopia.Epilepsia2019https://conductscience.org/library/papers/30597542PubMed
26,420,483Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway.J Biol Chem2015https://conductscience.org/library/papers/26420483PubMed
23,885,176Current and emerging treatments for absence seizures in young patients.Neuropsychiatr Dis Treat2013https://conductscience.org/library/papers/23885176PubMed
22,670,150Cognitive function of idiopathic childhood epilepsy.Korean J Pediatr2012https://conductscience.org/library/papers/22670150PubMed
22,164,192The cognitive impact of antiepileptic drugs.Ther Adv Neurol Disord2011https://conductscience.org/library/papers/22164192PubMed
17,963,043Neuropsychological deficits in childhood epilepsy syndromes.Neuropsychol Rev2007https://conductscience.org/library/papers/17963043PubMed
17,627,674Ethosuximide: from bench to bedside.CNS Drug Rev2007https://conductscience.org/library/papers/17627674PubMed
15,043,806Idiopathic Generalized Epilepsy.Curr Treat Options Neurol2004https://conductscience.org/library/papers/15043806PubMed
11,393,330Treatment of typical absence seizures and related epileptic syndromes.Paediatr Drugs2001https://conductscience.org/library/papers/11393330PubMed
9,764,957Therapeutic drug monitoring--antiepileptic drugs.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9764957PubMed
9,634,550On the action of the anti-absence drug ethosuximide in the rat and cat thalamus.J Neurosci1998https://conductscience.org/library/papers/9634550PubMed
8,549,027Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.Clin Pharmacokinet1995https://conductscience.org/library/papers/8549027PubMed
6,993,208Rational usage of therapeutic drug monitoring in antiepileptic treatment.Eur J Pediatr1980https://conductscience.org/library/papers/6993208PubMed
6,802,548Ethosuximide plasma concentrations: influence of age and associated concomitant therapy.Clin Pharmacokinet1982https://conductscience.org/library/papers/6802548PubMed
6,327,221Anticonvulsant drugs. An update.Drugs1984https://conductscience.org/library/papers/6327221PubMed
3,929,323Effects of phenobarbital, clonazepam, valproic acid, ethosuximide, and phenytoin on the delayed matching-to-sample performance of pigeons.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3929323PubMed
3,311,530Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311530PubMed
3,124,180Discriminative stimulus properties of ethosuximide in the pigeon.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/3124180PubMed
2,182,266Therapeutic drug monitoring of anticonvulsants. State of the art.Clin Pharmacokinet1990https://conductscience.org/library/papers/2182266PubMed
2,169,941Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction.Br J Pharmacol1990https://conductscience.org/library/papers/2169941PubMed

See all 22 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/805382

GET https://conductscience.org/api/papers/v1/805382/cited_by?page=2